{"name":"Deciphera Pharmaceuticals, LLC","slug":"deciphera-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":234123000,"netIncome":-194942000,"cash":83507000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DCC-2618","genericName":"DCC-2618","slug":"dcc-2618","indication":"Gastrointestinal stromal tumor (GIST), including imatinib-resistant and sunitinib-resistant disease","status":"phase_3"}]}],"pipeline":[{"name":"DCC-2618","genericName":"DCC-2618","slug":"dcc-2618","phase":"phase_3","mechanism":"DCC-2618 is a tyrosine kinase inhibitor that targets KIT, PDGFRA, and other receptor tyrosine kinases involved in gastrointestinal stromal tumors and other malignancies.","indications":["Gastrointestinal stromal tumor (GIST), including imatinib-resistant and sunitinib-resistant disease","Advanced systemic mastocytosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOOWhxVUdrM0w4bTI4NGR5c2hTblpKdWZrVnBJOVhHOVE3YmxGN0k4NFIzM21XSUJaaUdoZW1RQXlWMmNsNG5PeGdTUUVUXzF0YWI5U1pKWFc1U3VPWU9OOWpVQ1lhSzQzUndfYW5KajhTTmJ3aDlwWHozbG51Q2Nrall4NmlOb050QTF1TXFaOXRmSVlhSFV2VEdHejd6aEhhZ0k0VXVuNkI?oc=5","date":"2026-03-03","type":"pipeline","source":"Fierce Biotech","summary":"Ono’s Deciphera drops early-stage solid tumor drug for strategic reasons - Fierce Biotech","headline":"Ono’s Deciphera drops early-stage solid tumor drug for strategic reasons","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOVWxTMmNyWlk3dzJpOE9QaWJMbnE3VGxKTUE0MkljWnpiN1BlV2cyRV92VHlOZnBGWTczSUIwT2ZYdS1YaHJna3hiZmVGR2l1WWZkWFpvVmpGdXZfa25JWjFlSm9UUzdvei1GZFBvNWpSdEowdDRBSmRGSjY0WldtbmxlcTlMQ3lYR3BkZ1ZhS0liR1JOTGlfZ2p2Y09hRkVnOGdUVGw5YjZBQklxZjJodkc2OVM3bkFfSURqYXlDSmtjRGtxZ1M2Q21RMENqLXhlaEk2Y3FmTUhjbWRSQ1F6Y21GaEVOaEhCY08yRUNvNC03RjFaaGFiMlRJZlhGZlAy?oc=5","date":"2025-11-12","type":"trial","source":"Business Wire","summary":"Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025 - Business Wire","headline":"Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE02cUVMb2FqZkg0aU5Tdm8xVW1nYU5RVW9FaVJDeVo5YVJXcS1XZFI1ak1hUWNxT2xoMUc2a2hmbzdSNkRYOXg2SzFMSmdZeGl3bjF0OEVmazlRVXROREJRdzJiZkFaY0k?oc=5","date":"2025-08-26","type":"pipeline","source":"Anton Health","summary":"Limited Distribution Updates - Anton Health","headline":"Limited Distribution Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxOdzJ2bEEyVW1qT21aVllVSFZoRWlLd1lVYkI2cUlDZEVUaWhBbkdYMWRlREF6WnBaMVpmSF9wajVuazRxUnh3U21xMnhudE9TbnoyTGszRU13eHNDSm5XbHlNOHV1LUJYUFlCUG5YeG1MakdJRDB2OEtNTjIyTDc5WlJhX0tkTDVzZmk5WUJESHZ1RDV3NnNVN0JockJVVmVaUGM0bGI2NVZLUEZoSFp5TTdyS0JaT0pOdERoTnN3R3YwcTlhZDhQb3BzVEVoM1p6VEZWSTdKSFJUZFB3eWhYZFRxYlE3eTZiUFhXSGhLN1FJbkMzNDNYckJyMFFKUXpqTkVlc29vaDZWSTQ?oc=5","date":"2025-07-25","type":"pipeline","source":"Business Wire","summary":"Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT) - Business Wire","headline":"Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNdi1YcGg1WXZHNTZSRFdxaFV5YWlUeUQtOXRnTlpRNFB1cWxoNVdPTTA4YVpHQm9ZNFd3TEllWFdlbkJGLWdOaVFqMFF6Zk14WW54Skdmenp1MU1jS1RHRWFxQWsyVHJZUUFkUFdVblhfQUw3bDJnQU1PRGFtN0pkX055VU1NRnc?oc=5","date":"2025-04-29","type":"pipeline","source":"Fierce Biotech","summary":"Ono Pharma lays off 83 staffers at Cambridge, Massachusetts, site - Fierce Biotech","headline":"Ono Pharma lays off 83 staffers at Cambridge, Massachusetts, site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOVGVGbXlxV0hMbEpQRmVWTlo0YzQzcHN3emIwQncxWHNZaHVqVldPVWJiNTJFQV9FQjVWcDZUN1d6VDMtYWRNdDMzUDF4QXNEWUtHUU5ILUF4bG1fN0VoRlhOLU9yU3dDajVSRFhYMU9MWnJmTWJrQnVqVzlpRW9JUG1HZnNYUi1XWC1OM1dlQ0Rpa3Jx?oc=5","date":"2025-02-14","type":"regulatory","source":"Fierce Pharma","summary":"FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout - Fierce Pharma","headline":"FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxON1loMWcyUFNuazVrY2hVMHNpNF9NV0tveFJGdlJBWkZmcWNOOTZySjZPWmljYlh0cUxPcGhDLWNyYlI4eVZSRk10Qmd1eVZjQkZDdXFqNTUzTUtpVlAwV3VOTUNuMF8yYjJscG02OEJLWjVsX2hTOTVzT1RNLTd6Smt6dlpjNXpmUVM1eHZTb1E2d09HaW4xVlZyc1JNQ2xyZnQ1LXQ4cm56c2RhbFhLYmhGbXBDdTVzLTBSQzlEdXpNS1l5LTUtLWlleGZndlROZEZ6cG5xZXQxVG9TS0lnZ09GMlpJeExWdHd5YjNHWXdhelVqQmhNWlFUZVIwWHU5c2V3b19GS1g2S19iRWJkYWVueW5yZGdYazM0aGY2aXFfNkZiZ1RHaWJEVkcwRHM?oc=5","date":"2024-06-11","type":"deal","source":"PR Newswire","summary":"Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) - PR Newswire","headline":"Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQMmM0MVlPNWNUUW9KcnBINHhvaHY0N0tEcjNHQjR4dnNFOVg4OUFwM1pLeGRTdVQ3dEZ3d1ZBM2w0QlkwOVhOeFpsUmlHTkh1dnBzaXJaVy0yc0hHOVNkaWxQWUt3MkR4SWhTMU1HclBQVmJUcXpkdl9hWDZDMTdlQjd4Y1RqSmFwbnZfTjNPTXdRZHJEV2QzRExsdkhBQkZxTDNnR2FSb3BTakZOeHZoYnVWQVRHbmFvcWdEREJyWFpPZy1MLThndVF2dw?oc=5","date":"2024-04-30","type":"deal","source":"PR Newswire","summary":"ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals - PR Newswire","headline":"ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPX3VDbGNrNlF5cjluemxzdU5MRVRfQkJmNHhMYUl5RlFIZ21DNGtMZG1Vem9QcHJMNjI2QXl2NFZpZ05lNEt3Z1FBN1RxWlZtRFFUS3p5VzZnNTdYb3NVYUctam5rTWl0QUhJMjdZblMyMDV4UExTOVU5VE1uNWkwQkU2VlNudnduZndYVW5ScnNuUXcycVlkaA?oc=5","date":"2024-04-29","type":"deal","source":"Contract Pharma","summary":"Ono Pharmaceutical to Acquire Deciphera for $2.4B - Contract Pharma","headline":"Ono Pharmaceutical to Acquire Deciphera for $2.4B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQTVRTektmWTV3VEExZU93Rjc5clRIZHcxdm41U2F4cENjWjhKcklGYWNLeE1TUGVnbFpCd0RfRHFrSXJtS1htbHJSQmpfT25PTXVGOGxBNDNKZGFWdXRBTzlnRFdkdE5MWmNpTGZVX1ZiNFVreE1BNUZjZlNldHF0SDBxYXlhUjE5VEpBd24wSllaTW1BUHlvbEdUdDhRaldOUGU1UUNHNTVEX1oxOG8yc3hZcUhRMExrNnBQN0gxWFI?oc=5","date":"2024-04-29","type":"deal","source":"Stock Titan","summary":"Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion - Stock Titan","headline":"Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQLWRFRk94TjlBMGYyR0doVjRsYmdEbWY5OThZeXpwLXQtcW9rQjYyeFNacGx4UTNPQk5kNTNwZXRMd3ZpQkxGUHdUSkl6dUotM3pyZENXUmNtNWllNXJYLXAydDNURndFV1JCT0RXMTZOdlgtenVTMy1idFZLZzhUMDN0amVSbVEwQ1duUDNBNA?oc=5","date":"2024-04-29","type":"regulatory","source":"Fierce Pharma","summary":"Japan's Ono pays $2.4B for Qinlock maker Deciphera as biotech readies another approval run - Fierce Pharma","headline":"Japan's Ono pays $2.4B for Qinlock maker Deciphera as biotech readies another approval run","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQcDU2TDJYZnBmdXlrSkp3U1lycmtsMzVCZ2llTUtkR0xtaXQzYVU1X0x6bHZ0bUpuWnZPZUM2UmVQMW4tcjJiRkNGZkJKN0lpVVFtemdzU0dTU2ZWQS0xODdZVXdFNTRzcmczM0V0bTlyZlV1eVFUMGlEa2VranVDcUNKYXVCNGtQTmd2cVo3OA?oc=5","date":"2021-07-21","type":"pipeline","source":"drugdiscoverytrends.com","summary":"34 of the most innovative pharmaceutical products - drugdiscoverytrends.com","headline":"34 of the most innovative pharmaceutical products","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":0,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":0,"period":"2018-12-31"},{"value":0,"period":"2018-09-30"},{"value":0,"period":"2018-06-30"},{"value":0,"period":"2018-03-31"},{"value":0,"period":"2017-12-31"},{"value":0,"period":"2017-09-30"}],"grossProfit":19359000,"grossProfitHistory":[],"rdSpend":234123000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-194942000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":83507000,"cashHistory":[],"totalAssets":473566000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}